Currently, BNP, NT-proBNP, and MR-pro-ANP have been recommended and extensively accepted as biomarkers for the evaluation and differentiation of patients presenting in the ED or CCU/ICU with symptoms suggestive of HF (178, 182, 183). The gene discussed is NPPA; the disease is hydrops fetalis.